Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 − metastatic or advanced breast cancer patients: a network meta-analysis

Liu, Yiyuan; Wu, Jinyao; Ji, Zeqi; Chen, Lingzhi; Zou, Juan; Zheng, Jiehua; Lin, Weixun; Cai, Jiehui; Chen, Yaokun; Zheng, Daitian; Chen, Yexi; Li, Zhiyang

doi:10.1186/s12885-023-11322-2

BMC Cancer

Article metrics
Last updated: Sat, 18 May 2024 19:13:36 Z

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 − metastatic or advanced breast cancer patients: a network meta-analysis

Access & Citations

3152

Article Accesses
0

Web of Science
1

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com